{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-076241","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2023-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.301968+00:00","generated_at":"2026-06-10T18:52:29.775738+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ABVC BioPharma obtains waiver from Lind Global on market cap default condition through Feb 2024","bullets":["Lind Global waives any Event of Default for market cap below $12.5M for 10 consecutive days through Feb 23, 2024.","Lind retains conversion rights under Note sections 2.2(a) and 2.2(c)(2)(x), which could result in stock issued at significant discount.","Outstanding principal of Note is $2,754,167; Mandatory Default Amount set at 115% = $3,167,292.05.","If market cap does not increase or further waiver/amendment not obtained, an event of default could materially affect liquidity and operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-076241","json":"https://secwatch.observer/filing/0001213900-23-076241.json","markdown":"https://secwatch.observer/filing/0001213900-23-076241.md","text":"https://secwatch.observer/filing/0001213900-23-076241.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390023076241/0001213900-23-076241-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390023076241/ea185104-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T18:52:29.775738+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"35ffafdf9a1ee3aaf214aa4f49ed8f36ddced563","claim":"ABVC BIOPHARMA, INC. amended Letter Agreement with Lind Global Fund II LP (effective 2023-09-12).","evidence_excerpt":"On September 12, 2023, the Company and the Investor entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investor agreed to waive any default, any Event of Default, and any Mandatory Default Amount (each as defined in the Note) associated with the Company’s market capitalization being below $12.5 million for 10 consecutive days through February 23, 2024.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390023076241/0001213900-23-076241-index.htm","confidence":0.7,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"Lind Global Fund II LP"},{"label":"Effective","value":"2023-09-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}